We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

35 hedge funds and large institutions have $19.2M invested in OncoSec Medical Incorporated in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 34 → 35 (+1)

47% less capital invested

Capital invested by funds: $36.2M → $19.2M (-$17M)

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
10
Closed
7
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$210K
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$191K
3
BFM
Boothbay Fund Management
New York
+$187K
4
CC
Caxton Corporation
New Jersey
+$182K
5
Two Sigma Investments
Two Sigma Investments
New York
+$176K

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$2.76M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$748K
3
Millennium Management
Millennium Management
New York
-$583K
4
SCM
Stonepine Capital Management
Oregon
-$452K
5
Squarepoint
Squarepoint
New York
-$248K
Name Holding Trade Value Shares
Change 		Change in
Stake
APM
1
Avidity Partners Management
Texas
$7.87M -$2.76M -30,454 -19%
JGC
2
J. Goldman & Co
New York
$2.65M -$179K -1,977 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.94M -$748K -8,241 -21%
Holocene Advisors
4
Holocene Advisors
New York
$1.89M +$126K +1,385 +5%
Renaissance Technologies
5
Renaissance Technologies
New York
$1.1M +$210K +2,309 +15%
Two Sigma Investments
6
Two Sigma Investments
New York
$525K +$176K +1,942 +30%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$515K +$173K +1,909 +30%
CC
8
Caxton Corporation
New Jersey
$449K +$182K +2,003 +38%
Two Sigma Advisers
9
Two Sigma Advisers
New York
$445K +$191K +2,100 +41%
DADC
10
D.A. Davidson & Co
Montana
$326K -$4.54K -50 -0.9%
BlackRock
11
BlackRock
New York
$276K +$146K +1,614 +57%
SM
12
Salzhauer Michael
$133K +$41.2K +454 +27%
BFM
13
Boothbay Fund Management
New York
$127K +$187K +2,062 New
Northern Trust
14
Northern Trust
Illinois
$122K – – –
SSA
15
Schonfeld Strategic Advisors
New York
$99K -$26.8K -295 -16%
Millennium Management
16
Millennium Management
New York
$84K -$583K -6,425 -82%
GCP
17
GSA Capital Partners
United Kingdom
$83K +$122K +1,347 New
TAM
18
Tocqueville Asset Management
New York
$74K +$24.8K +273 +29%
SC
19
Shay Capital
New York
$70K +$103K +1,139 New
JF
20
Jump Financial
Illinois
$57K +$39.6K +436 +90%
State Street
21
State Street
Massachusetts
$56K +$82.2K +906 New
SPC
22
Sigma Planning Corp
Michigan
$38K -$4.08K -45 -7%
Envestnet Asset Management
23
Envestnet Asset Management
Illinois
$38K +$55.6K +613 New
VF
24
Virtu Financial
New York
$36K +$52.2K +575 New
HF
25
HRT Financial
New York
$34K -$14K -154 -22%
1
2

ONCS Hedge Fund Activity: Q2 2021 in Review

35 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2021, worth a combined $19.2M — down 47% from $36.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ONCS positions and 7 closed out — a net gain of 1 holder — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $210K. The largest seller was Avidity Partners Management, cutting an estimated $2.76M.

  • 35 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2021, up from 34 in Q1 2021.
  • Funds reported $19.2M of OncoSec Medical Incorporated stock for Q2 2021, down 47% quarter-over-quarter.
  • 8 funds opened new OncoSec Medical Incorporated positions in Q2 2021 and 7 closed out, a net change of +1 holder.
  • The largest OncoSec Medical Incorporated buyer in Q2 2021 was Renaissance Technologies, an estimated $210K added.
  • The largest OncoSec Medical Incorporated seller in Q2 2021 was Avidity Partners Management, an estimated $2.76M sold.

Based on aggregated 13F filings for Q2 2021.